Use of intravitreal bevacizumab or triamcinolone acetonide as a preoperative adjunct to vitrectomy for vitreous haemorrhage in diabetics

PURPOSE: To evaluate the effect of preoperative intravitreal bevacizumab (IVB) or triamcinolone (IVT) on the rate of early postvitrectomy hemorrhage in proliferative diabetic retinopathy (PDR). METHODS: Eligible eyes were assigned randomly to 1 of 3 groups: the IVB group received 1.25 mg bevacizumab...

ver descrição completa

Detalhes bibliográficos
Autor principal: Ferraz,Daniel Araújo (author)
Outros Autores: Morita,Celso (author), Preti,Rony Carlos (author), Nascimento,Vinicius Paganini (author), Maia Junior,Otacílio Oliveira (author), Barros,André Carvalho de (author), Takahashi,Beatriz Sayuri (author), Takahashi,Walter Yukihiko (author)
Formato: article
Idioma:eng
Publicado em: 2013
Assuntos:
Diabetic retinopathy/surgery
Vitrectomy
Angiogenesis inhibitors/therapeutic use
Triamcinolone/therapeutic use
Visual acuity
Texto completo:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802013000100003
País:Brasil
Oai:oai:scielo:S0034-72802013000100003

Texto Completo

http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802013000100003

Registros relacionados